Page last updated: 2024-11-05

thalidomide and Hyperthermia

thalidomide has been researched along with Hyperthermia in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Hyperthermia: An abnormal elevation of body temperature, usually as a result of inability to regulate core body temperature due to non-pathologic factors.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kalisch-Smith, JI1
Ved, N1
Sparrow, DB1

Reviews

1 review available for thalidomide and Hyperthermia

ArticleYear
Environmental Risk Factors for Congenital Heart Disease.
    Cold Spring Harbor perspectives in biology, 2020, 03-02, Volume: 12, Issue:3

    Topics: Alcohol Drinking; Animals; Diabetes Mellitus; Environmental Exposure; Gene-Environment Interaction;

2020